1. Home
  2. OLMA vs ALLT Comparison

OLMA vs ALLT Comparison

Compare OLMA & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • ALLT
  • Stock Information
  • Founded
  • OLMA 2006
  • ALLT 1996
  • Country
  • OLMA United States
  • ALLT Israel
  • Employees
  • OLMA N/A
  • ALLT N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • ALLT Telecommunications Equipment
  • Sector
  • OLMA Health Care
  • ALLT Telecommunications
  • Exchange
  • OLMA Nasdaq
  • ALLT Nasdaq
  • Market Cap
  • OLMA 378.9M
  • ALLT 342.5M
  • IPO Year
  • OLMA 2020
  • ALLT 2006
  • Fundamental
  • Price
  • OLMA $7.75
  • ALLT $9.37
  • Analyst Decision
  • OLMA Strong Buy
  • ALLT Buy
  • Analyst Count
  • OLMA 5
  • ALLT 1
  • Target Price
  • OLMA $24.00
  • ALLT N/A
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • ALLT 575.9K
  • Earning Date
  • OLMA 11-11-2025
  • ALLT 08-14-2025
  • Dividend Yield
  • OLMA N/A
  • ALLT N/A
  • EPS Growth
  • OLMA N/A
  • ALLT N/A
  • EPS
  • OLMA N/A
  • ALLT N/A
  • Revenue
  • OLMA N/A
  • ALLT $95,342,000.00
  • Revenue This Year
  • OLMA N/A
  • ALLT $10.64
  • Revenue Next Year
  • OLMA N/A
  • ALLT $15.76
  • P/E Ratio
  • OLMA N/A
  • ALLT N/A
  • Revenue Growth
  • OLMA N/A
  • ALLT 4.74
  • 52 Week Low
  • OLMA $2.86
  • ALLT $2.78
  • 52 Week High
  • OLMA $13.93
  • ALLT $10.77
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 64.67
  • ALLT 67.05
  • Support Level
  • OLMA $7.49
  • ALLT $8.94
  • Resistance Level
  • OLMA $8.40
  • ALLT $9.58
  • Average True Range (ATR)
  • OLMA 0.67
  • ALLT 0.43
  • MACD
  • OLMA 0.08
  • ALLT 0.13
  • Stochastic Oscillator
  • OLMA 75.63
  • ALLT 89.81

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

Share on Social Networks: